nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCG2—Lamivudine—hepatitis B	0.0793	0.735	CbGbCtD
Regorafenib—ABCB1—Lamivudine—hepatitis B	0.0286	0.265	CbGbCtD
Regorafenib—Lipase increased—Telbivudine—hepatitis B	0.0241	0.075	CcSEcCtD
Regorafenib—Amylase increased—Telbivudine—hepatitis B	0.0149	0.0463	CcSEcCtD
Regorafenib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0145	0.045	CcSEcCtD
Regorafenib—FLT1—blood plasma—hepatitis B	0.00862	0.0526	CbGeAlD
Regorafenib—Amylase increased—Lamivudine—hepatitis B	0.00839	0.0261	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0079	0.0246	CcSEcCtD
Regorafenib—UGT1A1—blood plasma—hepatitis B	0.00771	0.047	CbGeAlD
Regorafenib—KDR—blood plasma—hepatitis B	0.00729	0.0445	CbGeAlD
Regorafenib—KIT—blood plasma—hepatitis B	0.00646	0.0394	CbGeAlD
Regorafenib—FRK—liver—hepatitis B	0.00581	0.0355	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00539	0.0168	CcSEcCtD
Regorafenib—DDR2—liver—hepatitis B	0.00522	0.0318	CbGeAlD
Regorafenib—Neutropenia—Entecavir—hepatitis B	0.00506	0.0157	CcSEcCtD
Regorafenib—Dysphonia—Lamivudine—hepatitis B	0.00486	0.0151	CcSEcCtD
Regorafenib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00478	0.0149	CcSEcCtD
Regorafenib—BRAF—blood—hepatitis B	0.00471	0.0288	CbGeAlD
Regorafenib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00463	0.0144	CcSEcCtD
Regorafenib—Hepatobiliary disease—Entecavir—hepatitis B	0.00457	0.0142	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00454	0.0141	CcSEcCtD
Regorafenib—EPHX2—blood—hepatitis B	0.0045	0.0275	CbGeAlD
Regorafenib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00446	0.0138	CcSEcCtD
Regorafenib—CYP2C19—blood plasma—hepatitis B	0.00418	0.0255	CbGeAlD
Regorafenib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00418	0.013	CcSEcCtD
Regorafenib—Neutropenia—Telbivudine—hepatitis B	0.00416	0.0129	CcSEcCtD
Regorafenib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00416	0.0129	CcSEcCtD
Regorafenib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00415	0.0129	CcSEcCtD
Regorafenib—FLT4—blood—hepatitis B	0.00406	0.0248	CbGeAlD
Regorafenib—Alopecia—Entecavir—hepatitis B	0.00383	0.0119	CcSEcCtD
Regorafenib—Malnutrition—Entecavir—hepatitis B	0.00377	0.0117	CcSEcCtD
Regorafenib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00375	0.0117	CcSEcCtD
Regorafenib—BRAF—liver—hepatitis B	0.00369	0.0225	CbGeAlD
Regorafenib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00368	0.0114	CcSEcCtD
Regorafenib—CYP2C8—blood plasma—hepatitis B	0.00365	0.0223	CbGeAlD
Regorafenib—RET—blood—hepatitis B	0.00359	0.0219	CbGeAlD
Regorafenib—EPHX2—liver—hepatitis B	0.00352	0.0215	CbGeAlD
Regorafenib—Connective tissue disorder—Telbivudine—hepatitis B	0.0035	0.0109	CcSEcCtD
Regorafenib—FGFR2—blood—hepatitis B	0.00341	0.0208	CbGeAlD
Regorafenib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.0034	0.0106	CcSEcCtD
Regorafenib—Leukopenia—Entecavir—hepatitis B	0.00338	0.0105	CcSEcCtD
Regorafenib—EPHA2—blood—hepatitis B	0.00335	0.0204	CbGeAlD
Regorafenib—Gastroenteritis—Lamivudine—hepatitis B	0.00327	0.0102	CcSEcCtD
Regorafenib—CYP2B6—blood plasma—hepatitis B	0.00327	0.02	CbGeAlD
Regorafenib—TEK—blood—hepatitis B	0.00327	0.0199	CbGeAlD
Regorafenib—CYP2C9—blood plasma—hepatitis B	0.00324	0.0198	CbGeAlD
Regorafenib—UGT1A9—liver—hepatitis B	0.00322	0.0197	CbGeAlD
Regorafenib—Mediastinal disorder—Telbivudine—hepatitis B	0.00321	0.00997	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00319	0.00991	CcSEcCtD
Regorafenib—FLT4—liver—hepatitis B	0.00318	0.0194	CbGeAlD
Regorafenib—FLT1—blood—hepatitis B	0.00316	0.0193	CbGeAlD
Regorafenib—RAF1—blood—hepatitis B	0.00314	0.0192	CbGeAlD
Regorafenib—FGFR1—liver—hepatitis B	0.00313	0.0191	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00311	0.00967	CcSEcCtD
Regorafenib—Malnutrition—Telbivudine—hepatitis B	0.0031	0.00963	CcSEcCtD
Regorafenib—Infection—Entecavir—hepatitis B	0.00306	0.0095	CcSEcCtD
Regorafenib—Nervous system disorder—Entecavir—hepatitis B	0.00302	0.00938	CcSEcCtD
Regorafenib—Skin disorder—Entecavir—hepatitis B	0.00299	0.00929	CcSEcCtD
Regorafenib—PDGFRA—blood—hepatitis B	0.00296	0.0181	CbGeAlD
Regorafenib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00295	0.00915	CcSEcCtD
Regorafenib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00294	0.00914	CcSEcCtD
Regorafenib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00292	0.00907	CcSEcCtD
Regorafenib—UGT1A1—blood—hepatitis B	0.00282	0.0172	CbGeAlD
Regorafenib—KDR—blood—hepatitis B	0.00267	0.0163	CbGeAlD
Regorafenib—FGFR2—liver—hepatitis B	0.00266	0.0163	CbGeAlD
Regorafenib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00266	0.00826	CcSEcCtD
Regorafenib—Fatigue—Entecavir—hepatitis B	0.00266	0.00825	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00262	0.00814	CcSEcCtD
Regorafenib—EPHA2—liver—hepatitis B	0.00262	0.016	CbGeAlD
Regorafenib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00261	0.00811	CcSEcCtD
Regorafenib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00261	0.00811	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00259	0.00806	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00256	0.00795	CcSEcCtD
Regorafenib—TEK—liver—hepatitis B	0.00256	0.0156	CbGeAlD
Regorafenib—Gastrointestinal pain—Entecavir—hepatitis B	0.00252	0.00782	CcSEcCtD
Regorafenib—Nervous system disorder—Telbivudine—hepatitis B	0.00248	0.00771	CcSEcCtD
Regorafenib—Thrombocytopenia—Telbivudine—hepatitis B	0.00248	0.0077	CcSEcCtD
Regorafenib—CYP3A4—blood plasma—hepatitis B	0.00247	0.0151	CbGeAlD
Regorafenib—FLT1—liver—hepatitis B	0.00247	0.0151	CbGeAlD
Regorafenib—Skin disorder—Telbivudine—hepatitis B	0.00246	0.00763	CcSEcCtD
Regorafenib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00246	0.00763	CcSEcCtD
Regorafenib—RAF1—liver—hepatitis B	0.00246	0.015	CbGeAlD
Regorafenib—Abdominal pain—Entecavir—hepatitis B	0.00243	0.00756	CcSEcCtD
Regorafenib—Body temperature increased—Entecavir—hepatitis B	0.00243	0.00756	CcSEcCtD
Regorafenib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00238	0.00738	CcSEcCtD
Regorafenib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00238	0.00738	CcSEcCtD
Regorafenib—KIT—blood—hepatitis B	0.00237	0.0144	CbGeAlD
Regorafenib—Neutropenia—Lamivudine—hepatitis B	0.00234	0.00728	CcSEcCtD
Regorafenib—PDGFRA—liver—hepatitis B	0.00231	0.0141	CbGeAlD
Regorafenib—PDGFRB—blood—hepatitis B	0.00231	0.0141	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00222	0.00689	CcSEcCtD
Regorafenib—Asthenia—Entecavir—hepatitis B	0.00221	0.00686	CcSEcCtD
Regorafenib—UGT1A1—liver—hepatitis B	0.00221	0.0135	CbGeAlD
Regorafenib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00218	0.00679	CcSEcCtD
Regorafenib—Fatigue—Telbivudine—hepatitis B	0.00218	0.00678	CcSEcCtD
Regorafenib—Stomatitis—Lamivudine—hepatitis B	0.00218	0.00677	CcSEcCtD
Regorafenib—Pain—Telbivudine—hepatitis B	0.00216	0.00672	CcSEcCtD
Regorafenib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00216	0.0067	CcSEcCtD
Regorafenib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00211	0.00657	CcSEcCtD
Regorafenib—Diarrhoea—Entecavir—hepatitis B	0.00211	0.00655	CcSEcCtD
Regorafenib—KDR—liver—hepatitis B	0.00209	0.0127	CbGeAlD
Regorafenib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00207	0.00643	CcSEcCtD
Regorafenib—ABL1—blood—hepatitis B	0.00206	0.0126	CbGeAlD
Regorafenib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00206	0.00639	CcSEcCtD
Regorafenib—Abdominal pain—Telbivudine—hepatitis B	0.002	0.00621	CcSEcCtD
Regorafenib—Body temperature increased—Telbivudine—hepatitis B	0.002	0.00621	CcSEcCtD
Regorafenib—Connective tissue disorder—Lamivudine—hepatitis B	0.00197	0.00613	CcSEcCtD
Regorafenib—Vomiting—Entecavir—hepatitis B	0.00196	0.00608	CcSEcCtD
Regorafenib—Rash—Entecavir—hepatitis B	0.00194	0.00603	CcSEcCtD
Regorafenib—Dermatitis—Entecavir—hepatitis B	0.00194	0.00603	CcSEcCtD
Regorafenib—Headache—Entecavir—hepatitis B	0.00193	0.00599	CcSEcCtD
Regorafenib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00191	0.00593	CcSEcCtD
Regorafenib—Erythema multiforme—Lamivudine—hepatitis B	0.0019	0.00589	CcSEcCtD
Regorafenib—Rash—Adefovir Dipivoxil—hepatitis B	0.00189	0.00589	CcSEcCtD
Regorafenib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00189	0.00588	CcSEcCtD
Regorafenib—Headache—Adefovir Dipivoxil—hepatitis B	0.00188	0.00585	CcSEcCtD
Regorafenib—KIT—liver—hepatitis B	0.00185	0.0113	CbGeAlD
Regorafenib—Nausea—Entecavir—hepatitis B	0.00183	0.00568	CcSEcCtD
Regorafenib—Asthenia—Telbivudine—hepatitis B	0.00182	0.00564	CcSEcCtD
Regorafenib—Mediastinal disorder—Lamivudine—hepatitis B	0.00181	0.00562	CcSEcCtD
Regorafenib—PDGFRB—liver—hepatitis B	0.00181	0.011	CbGeAlD
Regorafenib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00178	0.00554	CcSEcCtD
Regorafenib—Alopecia—Lamivudine—hepatitis B	0.00177	0.00551	CcSEcCtD
Regorafenib—ABCB1—blood plasma—hepatitis B	0.00175	0.0107	CbGeAlD
Regorafenib—Malnutrition—Lamivudine—hepatitis B	0.00175	0.00543	CcSEcCtD
Regorafenib—Diarrhoea—Telbivudine—hepatitis B	0.00173	0.00538	CcSEcCtD
Regorafenib—Tremor—Lamivudine—hepatitis B	0.00164	0.00508	CcSEcCtD
Regorafenib—Anaemia—Lamivudine—hepatitis B	0.00161	0.00502	CcSEcCtD
Regorafenib—ABL1—liver—hepatitis B	0.00161	0.00983	CbGeAlD
Regorafenib—Vomiting—Telbivudine—hepatitis B	0.00161	0.005	CcSEcCtD
Regorafenib—Rash—Telbivudine—hepatitis B	0.0016	0.00496	CcSEcCtD
Regorafenib—Dermatitis—Telbivudine—hepatitis B	0.00159	0.00495	CcSEcCtD
Regorafenib—Headache—Telbivudine—hepatitis B	0.00158	0.00492	CcSEcCtD
Regorafenib—Leukopenia—Lamivudine—hepatitis B	0.00156	0.00486	CcSEcCtD
Regorafenib—CYP2C19—blood—hepatitis B	0.00153	0.00934	CbGeAlD
Regorafenib—Nausea—Telbivudine—hepatitis B	0.0015	0.00467	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00148	0.00459	CcSEcCtD
Regorafenib—Dry mouth—Lamivudine—hepatitis B	0.00145	0.00452	CcSEcCtD
Regorafenib—Infection—Lamivudine—hepatitis B	0.00142	0.0044	CcSEcCtD
Regorafenib—Nervous system disorder—Lamivudine—hepatitis B	0.0014	0.00434	CcSEcCtD
Regorafenib—Thrombocytopenia—Lamivudine—hepatitis B	0.0014	0.00434	CcSEcCtD
Regorafenib—Skin disorder—Lamivudine—hepatitis B	0.00138	0.0043	CcSEcCtD
Regorafenib—CYP2C8—blood—hepatitis B	0.00134	0.00815	CbGeAlD
Regorafenib—ABCG2—blood—hepatitis B	0.0013	0.00793	CbGeAlD
Regorafenib—Decreased appetite—Lamivudine—hepatitis B	0.00124	0.00385	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00123	0.00382	CcSEcCtD
Regorafenib—Fatigue—Lamivudine—hepatitis B	0.00123	0.00382	CcSEcCtD
Regorafenib—Pain—Lamivudine—hepatitis B	0.00122	0.00379	CcSEcCtD
Regorafenib—CYP2B6—blood—hepatitis B	0.0012	0.00731	CbGeAlD
Regorafenib—CYP2C19—liver—hepatitis B	0.0012	0.0073	CbGeAlD
Regorafenib—CYP2C9—blood—hepatitis B	0.00119	0.00724	CbGeAlD
Regorafenib—Gastrointestinal pain—Lamivudine—hepatitis B	0.00117	0.00362	CcSEcCtD
Regorafenib—Abdominal pain—Lamivudine—hepatitis B	0.00113	0.0035	CcSEcCtD
Regorafenib—Body temperature increased—Lamivudine—hepatitis B	0.00113	0.0035	CcSEcCtD
Regorafenib—CYP2C8—liver—hepatitis B	0.00104	0.00638	CbGeAlD
Regorafenib—Asthenia—Lamivudine—hepatitis B	0.00102	0.00318	CcSEcCtD
Regorafenib—ABCG2—liver—hepatitis B	0.00102	0.0062	CbGeAlD
Regorafenib—Diarrhoea—Lamivudine—hepatitis B	0.000975	0.00303	CcSEcCtD
Regorafenib—CYP2B6—liver—hepatitis B	0.000937	0.00572	CbGeAlD
Regorafenib—CYP2C9—liver—hepatitis B	0.000928	0.00566	CbGeAlD
Regorafenib—Vomiting—Lamivudine—hepatitis B	0.000906	0.00282	CcSEcCtD
Regorafenib—CYP3A4—blood—hepatitis B	0.000905	0.00552	CbGeAlD
Regorafenib—Rash—Lamivudine—hepatitis B	0.000899	0.00279	CcSEcCtD
Regorafenib—Dermatitis—Lamivudine—hepatitis B	0.000898	0.00279	CcSEcCtD
Regorafenib—Headache—Lamivudine—hepatitis B	0.000893	0.00277	CcSEcCtD
Regorafenib—Nausea—Lamivudine—hepatitis B	0.000847	0.00263	CcSEcCtD
Regorafenib—CYP3A4—liver—hepatitis B	0.000708	0.00432	CbGeAlD
Regorafenib—ABCB1—blood—hepatitis B	0.000641	0.00391	CbGeAlD
Regorafenib—ABCB1—liver—hepatitis B	0.000501	0.00306	CbGeAlD
Regorafenib—MAPK11—Immune System—NFKB1—hepatitis B	2.99e-05	7.37e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—hepatitis B	2.97e-05	7.32e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS2—hepatitis B	2.97e-05	7.31e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—hepatitis B	2.97e-05	7.3e-05	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—IL6—hepatitis B	2.96e-05	7.29e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—hepatitis B	2.95e-05	7.25e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL2—hepatitis B	2.94e-05	7.23e-05	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—hepatitis B	2.93e-05	7.22e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT2—hepatitis B	2.91e-05	7.16e-05	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—IL6—hepatitis B	2.91e-05	7.16e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—hepatitis B	2.89e-05	7.12e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL2—hepatitis B	2.88e-05	7.1e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL6—hepatitis B	2.85e-05	7.01e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CTNNB1—hepatitis B	2.83e-05	6.98e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—CTNNB1—hepatitis B	2.82e-05	6.95e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—F2—hepatitis B	2.82e-05	6.94e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TGFB1—hepatitis B	2.82e-05	6.94e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—CTNNB1—hepatitis B	2.78e-05	6.85e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CDKN1A—hepatitis B	2.77e-05	6.82e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—F2—hepatitis B	2.77e-05	6.81e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—hepatitis B	2.77e-05	6.81e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PTEN—hepatitis B	2.76e-05	6.8e-05	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—IL6—hepatitis B	2.76e-05	6.8e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.76e-05	6.79e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—CDKN1A—hepatitis B	2.76e-05	6.79e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—IL6—hepatitis B	2.75e-05	6.78e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTEN—hepatitis B	2.75e-05	6.77e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCR5—hepatitis B	2.75e-05	6.77e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NFKB1—hepatitis B	2.75e-05	6.77e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—hepatitis B	2.75e-05	6.76e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—hepatitis B	2.74e-05	6.74e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—IL6—hepatitis B	2.74e-05	6.74e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—hepatitis B	2.74e-05	6.74e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—hepatitis B	2.73e-05	6.72e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP2A6—hepatitis B	2.72e-05	6.71e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—CDKN1A—hepatitis B	2.72e-05	6.69e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—PTEN—hepatitis B	2.71e-05	6.68e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—NFKB1—hepatitis B	2.7e-05	6.65e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—hepatitis B	2.7e-05	6.64e-05	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—hepatitis B	2.68e-05	6.61e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—hepatitis B	2.67e-05	6.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CTNNB1—hepatitis B	2.64e-05	6.5e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CTNNB1—hepatitis B	2.64e-05	6.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—F2—hepatitis B	2.63e-05	6.47e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—F2—hepatitis B	2.62e-05	6.45e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CTNNB1—hepatitis B	2.62e-05	6.44e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—hepatitis B	2.6e-05	6.41e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CDKN1A—hepatitis B	2.58e-05	6.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PTEN—hepatitis B	2.58e-05	6.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CDKN1A—hepatitis B	2.57e-05	6.34e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—CTNNB1—hepatitis B	2.57e-05	6.33e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PTEN—hepatitis B	2.57e-05	6.32e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NFKB1—hepatitis B	2.56e-05	6.31e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CDKN1A—hepatitis B	2.56e-05	6.29e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NFKB1—hepatitis B	2.56e-05	6.29e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTEN—hepatitis B	2.55e-05	6.28e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—hepatitis B	2.54e-05	6.26e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.54e-05	6.25e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.52e-05	6.2e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGT1—hepatitis B	2.51e-05	6.18e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT1—hepatitis B	2.51e-05	6.18e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—CDKN1A—hepatitis B	2.51e-05	6.18e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—PTEN—hepatitis B	2.51e-05	6.17e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—hepatitis B	2.5e-05	6.16e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—hepatitis B	2.48e-05	6.11e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—hepatitis B	2.47e-05	6.07e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—hepatitis B	2.47e-05	6.07e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT2—hepatitis B	2.46e-05	6.06e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—hepatitis B	2.46e-05	6.05e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CTNNB1—hepatitis B	2.46e-05	6.05e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR5—hepatitis B	2.45e-05	6.04e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CTNNB1—hepatitis B	2.44e-05	6e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CTNNB1—hepatitis B	2.43e-05	5.99e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP2A6—hepatitis B	2.43e-05	5.99e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—hepatitis B	2.42e-05	5.95e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT2—hepatitis B	2.41e-05	5.94e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—hepatitis B	2.4e-05	5.92e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CDKN1A—hepatitis B	2.4e-05	5.91e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—hepatitis B	2.4e-05	5.9e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—hepatitis B	2.4e-05	5.9e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PTEN—hepatitis B	2.39e-05	5.89e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CDKN1A—hepatitis B	2.38e-05	5.87e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKB1—hepatitis B	2.38e-05	5.86e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—hepatitis B	2.38e-05	5.86e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTEN—hepatitis B	2.38e-05	5.85e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CDKN1A—hepatitis B	2.38e-05	5.85e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CTNNB1—hepatitis B	2.37e-05	5.84e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP2A6—hepatitis B	2.37e-05	5.84e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTEN—hepatitis B	2.37e-05	5.84e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—F2—hepatitis B	2.36e-05	5.81e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CTNNB1—hepatitis B	2.32e-05	5.71e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—hepatitis B	2.32e-05	5.71e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CDKN1A—hepatitis B	2.32e-05	5.71e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PTEN—hepatitis B	2.31e-05	5.7e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CTNNB1—hepatitis B	2.31e-05	5.69e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKB1—hepatitis B	2.3e-05	5.67e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—hepatitis B	2.28e-05	5.62e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CDKN1A—hepatitis B	2.27e-05	5.58e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.27e-05	5.58e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTEN—hepatitis B	2.26e-05	5.57e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CDKN1A—hepatitis B	2.26e-05	5.56e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PTEN—hepatitis B	2.25e-05	5.55e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKB1—hepatitis B	2.25e-05	5.54e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKB1—hepatitis B	2.24e-05	5.52e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.22e-05	5.46e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—hepatitis B	2.21e-05	5.44e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—hepatitis B	2.2e-05	5.41e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT2—hepatitis B	2.2e-05	5.41e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—hepatitis B	2.19e-05	5.4e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CTNNB1—hepatitis B	2.19e-05	5.4e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALB—hepatitis B	2.15e-05	5.29e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALB—hepatitis B	2.15e-05	5.29e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT2—hepatitis B	2.15e-05	5.28e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CDKN1A—hepatitis B	2.14e-05	5.27e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTEN—hepatitis B	2.14e-05	5.26e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT1—hepatitis B	2.13e-05	5.24e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGT1—hepatitis B	2.13e-05	5.24e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—hepatitis B	2.12e-05	5.23e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CTNNB1—hepatitis B	2.12e-05	5.21e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—hepatitis B	2.11e-05	5.2e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.1e-05	5.18e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—F2—hepatitis B	2.1e-05	5.18e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—hepatitis B	2.08e-05	5.11e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—hepatitis B	2.07e-05	5.09e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.07e-05	5.09e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CDKN1A—hepatitis B	2.07e-05	5.09e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTEN—hepatitis B	2.06e-05	5.08e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKB1—hepatitis B	2.05e-05	5.05e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—hepatitis B	2.05e-05	5.04e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT2—hepatitis B	2.01e-05	4.94e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CTNNB1—hepatitis B	2e-05	4.91e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—hepatitis B	1.98e-05	4.89e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CTNNB1—hepatitis B	1.98e-05	4.87e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—hepatitis B	1.97e-05	4.85e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—hepatitis B	1.97e-05	4.84e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CTNNB1—hepatitis B	1.95e-05	4.81e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CDKN1A—hepatitis B	1.95e-05	4.8e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTEN—hepatitis B	1.95e-05	4.79e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.94e-05	4.77e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKB1—hepatitis B	1.94e-05	4.77e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CDKN1A—hepatitis B	1.93e-05	4.75e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTEN—hepatitis B	1.93e-05	4.74e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKB1—hepatitis B	1.92e-05	4.72e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CDKN1A—hepatitis B	1.91e-05	4.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTEN—hepatitis B	1.9e-05	4.69e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGT1—hepatitis B	1.9e-05	4.67e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT1—hepatitis B	1.9e-05	4.67e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—hepatitis B	1.9e-05	4.67e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—hepatitis B	1.88e-05	4.63e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—hepatitis B	1.88e-05	4.62e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—hepatitis B	1.86e-05	4.59e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGT1—hepatitis B	1.85e-05	4.56e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT1—hepatitis B	1.85e-05	4.56e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CTNNB1—hepatitis B	1.83e-05	4.51e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALB—hepatitis B	1.82e-05	4.49e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CTNNB1—hepatitis B	1.8e-05	4.43e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CDKN1A—hepatitis B	1.79e-05	4.41e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—hepatitis B	1.79e-05	4.4e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKB1—hepatitis B	1.78e-05	4.38e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—hepatitis B	1.77e-05	4.36e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—hepatitis B	1.77e-05	4.36e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—hepatitis B	1.76e-05	4.34e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CDKN1A—hepatitis B	1.76e-05	4.33e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—hepatitis B	1.75e-05	4.32e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKB1—hepatitis B	1.75e-05	4.3e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGT1—hepatitis B	1.73e-05	4.26e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT1—hepatitis B	1.73e-05	4.26e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.73e-05	4.26e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—hepatitis B	1.73e-05	4.25e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—hepatitis B	1.72e-05	4.23e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CTNNB1—hepatitis B	1.71e-05	4.2e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CTNNB1—hepatitis B	1.7e-05	4.19e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—hepatitis B	1.69e-05	4.17e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CDKN1A—hepatitis B	1.67e-05	4.11e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—hepatitis B	1.66e-05	4.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CDKN1A—hepatitis B	1.66e-05	4.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—hepatitis B	1.66e-05	4.09e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKB1—hepatitis B	1.66e-05	4.08e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKB1—hepatitis B	1.65e-05	4.07e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—hepatitis B	1.64e-05	4.03e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—hepatitis B	1.64e-05	4.03e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—hepatitis B	1.63e-05	4.02e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—hepatitis B	1.61e-05	3.97e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—hepatitis B	1.61e-05	3.96e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—hepatitis B	1.6e-05	3.95e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—hepatitis B	1.6e-05	3.93e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—hepatitis B	1.59e-05	3.92e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—hepatitis B	1.59e-05	3.91e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—hepatitis B	1.58e-05	3.89e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.58e-05	3.88e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—hepatitis B	1.56e-05	3.85e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—hepatitis B	1.54e-05	3.8e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CTNNB1—hepatitis B	1.53e-05	3.78e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CDKN1A—hepatitis B	1.5e-05	3.69e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—hepatitis B	1.5e-05	3.68e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—hepatitis B	1.5e-05	3.68e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKB1—hepatitis B	1.49e-05	3.66e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—hepatitis B	1.49e-05	3.66e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—hepatitis B	1.48e-05	3.65e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—hepatitis B	1.48e-05	3.64e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.46e-05	3.6e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—hepatitis B	1.45e-05	3.58e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—hepatitis B	1.45e-05	3.56e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—hepatitis B	1.42e-05	3.49e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—hepatitis B	1.41e-05	3.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—hepatitis B	1.41e-05	3.47e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—hepatitis B	1.41e-05	3.47e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—hepatitis B	1.39e-05	3.42e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—hepatitis B	1.38e-05	3.4e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—hepatitis B	1.38e-05	3.39e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CTNNB1—hepatitis B	1.37e-05	3.37e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CDKN1A—hepatitis B	1.34e-05	3.29e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—hepatitis B	1.34e-05	3.29e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—hepatitis B	1.33e-05	3.28e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—hepatitis B	1.33e-05	3.28e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—hepatitis B	1.33e-05	3.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKB1—hepatitis B	1.33e-05	3.27e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT2—hepatitis B	1.32e-05	3.26e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—hepatitis B	1.32e-05	3.24e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—hepatitis B	1.29e-05	3.17e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—hepatitis B	1.24e-05	3.05e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—hepatitis B	1.22e-05	3e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—hepatitis B	1.22e-05	2.99e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—hepatitis B	1.2e-05	2.96e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—hepatitis B	1.2e-05	2.95e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—hepatitis B	1.19e-05	2.93e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT1—hepatitis B	1.14e-05	2.81e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—hepatitis B	1.14e-05	2.81e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—hepatitis B	1.14e-05	2.8e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—hepatitis B	1.13e-05	2.79e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—hepatitis B	1.13e-05	2.78e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—hepatitis B	1.12e-05	2.75e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—hepatitis B	1.11e-05	2.72e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—hepatitis B	1.1e-05	2.7e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—hepatitis B	1.04e-05	2.56e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—hepatitis B	1.04e-05	2.55e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—hepatitis B	1.02e-05	2.51e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—hepatitis B	1.02e-05	2.51e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—hepatitis B	1.01e-05	2.49e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—hepatitis B	9.86e-06	2.43e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—hepatitis B	9.35e-06	2.3e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—hepatitis B	9.21e-06	2.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—hepatitis B	9.1e-06	2.24e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—hepatitis B	8.63e-06	2.12e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—hepatitis B	8.33e-06	2.05e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—hepatitis B	7.7e-06	1.9e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—hepatitis B	7.52e-06	1.85e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—hepatitis B	7.03e-06	1.73e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—hepatitis B	6.07e-06	1.49e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—hepatitis B	4.63e-06	1.14e-05	CbGpPWpGaD
